To advance plant-based production of Human Proteins, to lower the cost for commercialization of products related to human health, animal health, and food safety.
PLANT-BASED MOLECULAR FARMING
Traditional methods of production take two to six months. Our plant-based expression and purification method takes only 12 days. We offer faster production and lower cost resulting in rapid therapeutic development.
MNPharm is currently working with research organizations and various manufacturers in need of lower priced recombinant proteins. Bio-research involves repetitive testing to reach a positive conclusion. Traditional methods of protein production for testing is very costly, time consuming and inefficient.
Plants are Safer: Most of the traditional methods used to produce therapeutic proteins are animal based and come with the risk of microbial contamination caused by animal bacteria. Using plants to produce protein eliminates the risk for microbial contamination.
Rapid Response: The World Health Organization is concerned with rapid response to epidemics. In an emergency response situation, our plants would yield a high volume of necessary protein in days whereas traditional methods for protein production require months to achieve the same level of production.
Founder and CEO
Experienced entrepreneur, most recent starting MNPharm. A biotech company genetically altering plants to grow and refine into research grade proteins.
Another experienced entrepreneur and local politician. Driving the day to day operations for growing MNPharm.
Diana Trujillo. PhD
Chief Science Officer
Smartest person in the office according to Jeff! She is the brains behind the lab and product development.
Cheif QA Officer
Experienced business leader with a wide range of experience in business development, new product development, and obtaining financial targets with a global team.